Inhalon Biopharma Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$21.3M
Company Overview
Inhalon Biopharma Inc. is a clinical-stage biotechnology company developing inhaled antibody treatments for acute respiratory infections such as RSV, influenza, and SARS-CoV-2.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inhalon Biopharma Inc. Comparables
Compare Inhalon Biopharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pulmocide | 76% | |
| Mucommune, LLC | 73% | |
| Synairgen plc | 70% | |
Inhalon Biopharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Series A | Jun 30, 2022 | ||||
| Grant | May 26, 2021 | ||||
| Seed | Aug 26, 2020 | ||||
| Seed | Mar 20, 2019 |
Inhalon Biopharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thiel Foundation | Seed |
| Berkeley Catalyst Fund | Series A, Seed |
| JSR Life Sciences | Series A |
| Life Science Angels | Series A, Seed |
| Band of Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Human challenge trial initiated for RSV treatment.
Inhalon Biopharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inhalon Biopharma Inc.'s valuation, stock price, and market status.